Hypertrichosis induced by latanoprost [3]

Journal of the American Academy of Dermatology

Volumn 44, Issue 4, 2001, Pages 721-723

  Demitsu, T ^a   Manabe, M ^a   Harima, N ^a   Sugiyama, T ^a   Yoneda, K ^a   Yamada, N ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST;

CONJUNCTIVITIS; DRUG EFFECT; EYELASH; GLAUCOMA; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; LETTER; PRIORITY JOURNAL;

EID: 0035094875     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.111625     Document Type: Letter

References (6)

1. Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States
2. A preliminary risk-benefit assessment of latanoprost and unoprostone in open-angle glaucoma and ocular hypertension
3. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost
4. The stimulation of the initiation of DNA synthesis and cell division in Swiss mouse 3T3 cells by prostaglandin F2 alpha requires specific functional groups in the molecule
5. Mitogenic signaling by prostaglandins in chemically transformed mouse fibroblasts: Comparison with phorbol esters and insulin
6. Topical or systemic 16, 16 dm prostaglandin E2 or WR-2721 (WR-1065) protects mice from alopecia after fractionated irradiation